Order Article Reprints

Perri F, Longo F, Fusco R, D’Alessio V, Aversa C, Pavone E, Pontone M, Marciano ML, Villano S, Franco P, et al. Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial. Cancers. 2021; 13(9):2210. https://doi.org/10.3390/cancers13092210

Perri, Francesco, Francesco Longo, Roberta Fusco, Valeria D’Alessio, Corrado Aversa, Ettore Pavone, Monica Pontone, Maria Luisa Marciano, Salvatore Villano, Pierluigi Franco, and et al. 2021. "Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial" Cancers 13, no. 9: 2210. https://doi.org/10.3390/cancers13092210

Perri, F., Longo, F., Fusco, R., D’Alessio, V., Aversa, C., Pavone, E., Pontone, M., Marciano, M. L., Villano, S., Franco, P., Togo, G., Fazio, G. R. D., Ordano, D., Maglitto, F., Salzano, G., Maglione, M. G., Guida, A., & Ionna, F. (2021). Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial. Cancers, 13(9), 2210. https://doi.org/10.3390/cancers13092210